Mesoblast, Limited


About

Mesoblast is a world leader in developing innovative cellular medicines.

We have established what we believe is the industry’s most clinically advanced and diverse portfolio of cell-based products with five programs in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2.

All our clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.

Contact

55 Collins Street , Level 39
Corporate Headquarters
Melbourne 3000
Australia

Get Directions

Upgrade Your Listing

Fax: 61-3-9639-6030

Visit Website